Related Experiment Video
Updated: Aug 8, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
The International Nifedipine GITS Study of Intervention as a Goal in Hypertension Treatment (INSIGHT) trial
1Cattedra di Medicina Interna, Università di Milano, Ospedale S. Gerardo, Monza, Italy.
Insights
The INSIGHT trial investigated if nifedipine GITS improves outcomes in hypertensive patients with risk factors compared to diuretics. It assessed the prognostic influence of different antihypertensive treatments.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Trials
Background:
- Antihypertensive drug treatment reduces cardiovascular risks, but not to baseline levels.
- Newer agents like calcium antagonists, ACE inhibitors, and angiotensin II receptor antagonists are being studied to enhance benefits.
- Existing treatments like diuretics and beta-blockers have limitations in risk reduction.
Purpose of the Study:
- To evaluate the prognostic influence of nifedipine GITS versus a combined thiazide and potassium-sparing diuretic.
- To assess antihypertensive treatment in patients with multiple cardiovascular risk factors.
- To provide preliminary data on the INSIGHT trial's design and rationale.
Main Methods:
- Prospective, randomized controlled trial design.
- Comparison of nifedipine GITS with a standard diuretic regimen.
- Inclusion of hypertensive patients with hypercholesterolemia, smoking, diabetes, and left ventricular hypertrophy.
Main Results:
- Preliminary data and substudy information are available.
- The study focuses on the prognostic impact of different antihypertensive strategies.
- Specific outcome data is pending full trial completion.
Conclusions:
- The INSIGHT trial is crucial for understanding advanced antihypertensive therapy in high-risk populations.
- Results will inform optimal treatment strategies for complex hypertension.
- Further data is needed to confirm the comparative efficacy of nifedipine GITS.
Abstract:
Several trials have shown that antihypertensive drug treatment decreases cardiovascular morbidity and mortality rates. They have also shown, however, that the risk is not decreased to the level of nonhypertensive patients. Trials are therefore underway to determine whether the benefits achieved by older drugs, such as diuretics and beta blockers, can be enhanced by using newer classes of antihypertensive agents, such as calcium antagonists, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin II receptor antagonists. Among these trials, the International Nifedipine GITS Study of Intervention as a Goal in Hypertension Treatment (INSIGHT) is of special interest because it is the first study to address, in a prospective fashion, the prognostic influence of antihypertensive treatment (nifedipine GITS vs a combined thiazide and potassium-sparing diuretic) in hypertensive patients with concomitant risk factors such as hypercholesterolemia, cigarette smoking, diabetes, and left ventricular hypertrophy. This article briefly describes the rationale and design of the INSIGHT trial and cites the substudies and the preliminary data available.
Related Concept Videos
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Angina IV: Management
Angina V: Nursing Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management

